Cargando…
Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario
Glioblastoma (GBM) is the most common and aggressive central nervous system tumor, requiring multimodal management. Due to its malignant behavior and infiltrative growth pattern, GBM is one of the most difficult tumors to treat and gross total resection is still considered to be the first crucial st...
Autores principales: | Bianconi, Andrea, Palmieri, Giuseppe, Aruta, Gelsomina, Monticelli, Matteo, Zeppa, Pietro, Tartara, Fulvio, Melcarne, Antonio, Garbossa, Diego, Cofano, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295612/ https://www.ncbi.nlm.nih.gov/pubmed/37371615 http://dx.doi.org/10.3390/biomedicines11061520 |
Ejemplares similares
-
How Reliable Is Fluorescence-Guided Surgery in Low-Grade Gliomas? A Systematic Review Concerning Different Fluorophores
por: Bianconi, Andrea, et al.
Publicado: (2023) -
Let Me See: Correlation between 5-ALA Fluorescence and Molecular Pathways in Glioblastoma: A Single Center Experience
por: Specchia, Francesco Maria Calamo, et al.
Publicado: (2021) -
Systematic Review on Tumor Microenvironment in Glial Neoplasm: From Understanding Pathogenesis to Future Therapeutic Perspectives
por: Bianconi, Andrea, et al.
Publicado: (2022) -
Management of Extramedullary Intradural Spinal Tumors: The Impact of Clinical Status, Intraoperative Neurophysiological Monitoring and Surgical Approach on Outcomes in a 12-Year Double-Center Experience
por: Cofano, Fabio, et al.
Publicado: (2020) -
Fluorescence-Guided Surgery in Glioblastoma: 5-ALA, SF or Both? Differences between Fluorescent Dyes in 99 Consecutive Cases
por: Zeppa, Pietro, et al.
Publicado: (2022)